Glembatumumab (Anti-GPNMB)
Glembatumumab (Anti-GPNMB) (A2475-GRP)
Products
Description
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2475 |